Conjunctivitis Therapeutics Market

Global Conjunctivitis Therapeutics Market Size, Share & Trends Analysis Report, By Disease Type (Allergic Conjunctivitis, Bacterial Conjunctivitis, Viral Conjunctivitis), By Formulation Type (Ointment, Drops, Drugs) Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025317 | Category : Pharmaceuticals | Delivery Format: /

The global conjunctivitis therapeutics market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Conjunctivitis is a kind of eye condition, which is commonly known as pink eye. The market is projected to show substantial growth due to the high number of people suffering from allergic conjunctivitis and the easier availability of the treatment across the globe. Although the disease is very common, treatment for it is easily available globally. Generally, conjunctivitis is self diagnosable and there is the minimum need of undergoing any diagnostic test for it.

Emerging economies such as India also witnessed a high prevalence of the disease. According to an article published by the journal Clinical Epidemiology and Global Health, it was discovered that during the year 2019, the prevalence of allergic conjunctivitis was around 12.22% and the number of men suffering from this disease is higher than that of women in India. The epidemiology of the disease is similar in other Asian countries such as China. Hence, due to the high prevalence of the disease, the market is projected to have a steady growth during the forecast period.

Some key players operating in the market include Novartis International AG, Bausch & Lomb Incorporated, Allergan, NicOx S.A., Alembic Pharmaceuticals, among others. These players are aiming to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launches and development in the existing product portfolio, and so on.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape:  Novartis International AG, Bausch & Lomb Incorporated, Allergan, NicOx S.A., Alembic Pharmaceuticals, among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Conjunctivitis Therapeutics Market by Segment

By Disease Type 

Allergic Conjunctivitis

Bacterial Conjunctivitis

Viral Conjunctivitis

By Formulation Type 

Ointment

Drops

Drugs

Global Conjunctivitis Therapeutics Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World